HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Mustjoki Selected Research

Imatinib Mesylate (Gleevec)

1/2017Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
7/2013Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
11/2007Appearance of bone marrow lymphocytosis predicts an optimal response to imatinib therapy in patients with chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Mustjoki Research Topics

Disease

9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017 - 11/2007
6Leukemia
01/2021 - 12/2000
3Neoplasms (Cancer)
01/2018 - 12/2000
3Lymphocytosis
10/2011 - 11/2007
2Philadelphia Chromosome
07/2013 - 01/2010
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2018
1Blast Crisis (Blast Phase)
05/2015
1Large Granular Lymphocytic Leukemia
04/2015
1Thrombocytopenia (Thrombopenia)
04/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2013
1Pleural Effusion (Pleural Effusions)
04/2013
1Disease Progression
06/2001
1Circulating Neoplastic Cells
12/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2000
1Pathologic Processes
12/2000

Drug/Important Bio-Agent (IBA)

5Dasatinib (BMS 354825)FDA Link
01/2016 - 08/2009
4Tyrosine Kinase InhibitorsIBA
01/2017 - 01/2010
3Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 11/2007
2tinostamustineIBA
01/2021 - 01/2020
2Thomsen-Friedenreich antibodiesIBA
01/2021 - 01/2020
1nilotinibFDA Link
10/2017
1Immunomodulating AgentsIBA
01/2017
1InterferonsIBA
01/2016
1amsonic acid (DAS)IBA
01/2016
1Methotrexate (Mexate)FDA LinkGeneric
04/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2001
1PlasminogenIBA
12/2000
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2000
1Urokinase Plasminogen Activator ReceptorsIBA
12/2000

Therapy/Procedure

9Therapeutics
01/2018 - 11/2007
1Drug Therapy (Chemotherapy)
12/2000